358 / 1851
Evidence for effect of a combined approach
03/01/13
Disease
Induction
Concomitant
Adjuvant
GBM
÷
+( Level II)
+ (Level II)
HNSCC
÷/+ (Level I)
+++ (Level I)
÷ (Level II)
NSCLC
+( Level I)
+++ (Level I)
÷
SCLC
+++ (Level I)
+++ (Level I)
+++ (Level I)
CCU
÷/+ (Level I)
+++ (Level I)
÷
Oesophagus
÷
+++ (Level I)
÷
Rectum
÷
+++ (Level II)
÷
Anal
÷
+++ (Level II)
÷